Optum Assessing Impact of First Take-Home COVID Test

Optum Workers’ Comp and Auto No-Fault said it is evaluating the impact of a prescription at-home COVID-19 test kit on its standard formularies and viral infection supplemental formulary. The U.S. Food and Drug Administration on Nov. 17 authorized the use of the Lucira COVID-19 nasal swab test kit, Optum said. The single-use kit can be used at home for people 14 and older and for patients of any age in point-of-care settings including doctor offices, urgent care facilities and hospitals. Test results are displayed in less than 30 minutes. Lucira Health reportedly said it plans to make ...